Gokce Belge Bilgin, Cem Bilgin, Matthew A. Frick, Doris E. Wenger, Matthew P. Thorpe, Stephen M. Broski
{"title":"[¹⁸F] FDG PET/CT在腺癌分期中的应用","authors":"Gokce Belge Bilgin, Cem Bilgin, Matthew A. Frick, Doris E. Wenger, Matthew P. Thorpe, Stephen M. Broski","doi":"10.1007/s00259-025-07213-2","DOIUrl":null,"url":null,"abstract":"<p>Hidradenocarcinoma is a rare and aggressive malignant cutaneous adnexal tumor that originates from the intradermal ducts of eccrine sweat glands. Herein, we report a case of hidradenocarcinoma that had transformed from a previously excised benign hidradenoma. [<sup>18</sup>F] FDG PET/CT revealed an FDG-avid mass in the left calf, and extensive metastatic disease, including soft tissue, pulmonary, osseous, and extensive nodal metastases. This case underscores the potential for malignant transformation of hidradenoma and highlights the utility of [<sup>18</sup>F] FDG PET/CT in staging hidradenocarcinoma.</p>","PeriodicalId":11909,"journal":{"name":"European Journal of Nuclear Medicine and Molecular Imaging","volume":"67 1","pages":""},"PeriodicalIF":7.6000,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The utility of [¹⁸F] FDG PET/CT in staging hidradenocarcinoma\",\"authors\":\"Gokce Belge Bilgin, Cem Bilgin, Matthew A. Frick, Doris E. Wenger, Matthew P. Thorpe, Stephen M. Broski\",\"doi\":\"10.1007/s00259-025-07213-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Hidradenocarcinoma is a rare and aggressive malignant cutaneous adnexal tumor that originates from the intradermal ducts of eccrine sweat glands. Herein, we report a case of hidradenocarcinoma that had transformed from a previously excised benign hidradenoma. [<sup>18</sup>F] FDG PET/CT revealed an FDG-avid mass in the left calf, and extensive metastatic disease, including soft tissue, pulmonary, osseous, and extensive nodal metastases. This case underscores the potential for malignant transformation of hidradenoma and highlights the utility of [<sup>18</sup>F] FDG PET/CT in staging hidradenocarcinoma.</p>\",\"PeriodicalId\":11909,\"journal\":{\"name\":\"European Journal of Nuclear Medicine and Molecular Imaging\",\"volume\":\"67 1\",\"pages\":\"\"},\"PeriodicalIF\":7.6000,\"publicationDate\":\"2025-03-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Nuclear Medicine and Molecular Imaging\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00259-025-07213-2\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Nuclear Medicine and Molecular Imaging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00259-025-07213-2","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
The utility of [¹⁸F] FDG PET/CT in staging hidradenocarcinoma
Hidradenocarcinoma is a rare and aggressive malignant cutaneous adnexal tumor that originates from the intradermal ducts of eccrine sweat glands. Herein, we report a case of hidradenocarcinoma that had transformed from a previously excised benign hidradenoma. [18F] FDG PET/CT revealed an FDG-avid mass in the left calf, and extensive metastatic disease, including soft tissue, pulmonary, osseous, and extensive nodal metastases. This case underscores the potential for malignant transformation of hidradenoma and highlights the utility of [18F] FDG PET/CT in staging hidradenocarcinoma.
期刊介绍：
The European Journal of Nuclear Medicine and Molecular Imaging serves as a platform for the exchange of clinical and scientific information within nuclear medicine and related professions. It welcomes international submissions from professionals involved in the functional, metabolic, and molecular investigation of diseases. The journal's coverage spans physics, dosimetry, radiation biology, radiochemistry, and pharmacy, providing high-quality peer review by experts in the field. Known for highly cited and downloaded articles, it ensures global visibility for research work and is part of the EJNMMI journal family.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
